Leading the way to a cure

Lupus News

Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)

September 17, 2012
HAYWARD, Calif., Sept. 17, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and...

See full story >

ALR Annual Walk Aims to End Lupus

September 13, 2012
In 2008, Melissa Carter noticed she had a rash on her face and concluded it was an allergic reaction. Things took a turn for the worse when she began to have swollen hands and stiff joints.

See full story >

New Silicon Chips Help Identify Patients with Lupus

August 21, 2012
Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon...

See full story >

Lupus Risk Linked to Staph Bacteria: Study

August 9, 2012
Previous studies have pointed to gender, ethnicity (lupus is two to three times more prevalent among women of color than it is among Caucasian women) and even the use of some prescription drugs as...

See full story >

Shannon Boxx Competing for Gold Medal with Lupus

July 24, 2012
Shannon Boxx is a midfielder on the U.S. women's soccer team which will be competing in the 2012 London Olympics. Boxx will be trying to snag her third straight Olympic gold medal. I find the...

See full story >

Items 96 - 100 of 100  Previous11121314151617181920

1.5 million

people in the U.S. have Lupus.

100 million

dollars committed to lupus research by the Alliance for Lupus Research.

We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.

Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.